Prognostic value of circulating dead monocytes in patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention

Cardiology

Volumn 117, Issue 2, 2010, Pages 131-139

  Tsai, Tzu Hsien ^a   Lin, Yu Chun ^a   Sun, Cheuk Kwan ^b   Chung, Sheng Ying ^a   Chai, Han Tan ^a   Yang, Cheng Hsu ^a   Chen, Shyh Ming ^a   Hang, Chi Ling ^a   Chen, Chien Jen ^a   Chua, Sarah ^a   Wu, Chiung Jen ^a   Leu, Steve ^a   Yip, Hon Kan ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Acute ST elevation myocardial infarction; Cell death; Primary percutaneous coronary artery intervention; Prognostic outcome

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE; LIPOCORTIN 5; PROPIDIUM IODIDE;

ADULT; APOPTOSIS; ARTICLE; CELL DEATH; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; FEMALE; FLOW CYTOMETRY; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HUMAN CELL; HYPOTHESIS; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; ANGIOPLASTY, BALLOON, CORONARY; BIOLOGICAL MARKERS; CELL DEATH; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FLOW CYTOMETRY; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MONOCYTES; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; ROC CURVE;

EID: 77958130607     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320208     Document Type: Article

References (27)

1. Van der Wall AC, Becker AE, van der Loos CM, Das PK: Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994;89:36-44.
2. Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R: Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997;336:1276-1282.
3. Sheu JJ, Chua S, Sun CK, Chang LT, Yen CH, Wu CJ, et al: Intra-coronary administration of cyclosporine limits infarct size, attenuates remodeling and preserves left ventricular function in porcine acute anterior infarction. Inter J Cardiol 2010, E-pub ahead of print.
4. Frangogiannis NG, Smith CW, Entman ML: The inflammatory response in myocardial infarction. Cardiovasc Res 2002;53:31-47.
5. Lambert JM, Lopez EF, Lindsey ML: Macrophage roles following myocardial infarction. Int J Cardiol 2008;130:147-158.
6. Frangogiannis NG: The immune system and cardiac repair. Pharmacol Res 2008;58:88-111.
7. De Scheerder I, Vanderkerckhove J, Robbrecht J, Algoed L, De Buyzere M, De Langhe J, et al: Post-cardiac injury syndrome and an increased humoral immune response against the major contractile proteins (actin and myosin). Am J Cardiol 1985;56:631-633.
8. Lange LG, Schreiner GF: Immune mechanisms of cardiac disease. New Engl J Med 1994;330:1129-1135.
9. Bloom NV, Leor J, Ohad DG, Hasin Y, Amar M, Fixler R, et al: Cytotoxic T lymphocytes are activated following myocardial infarction and can recognize and kill healthy myocytes in vitro. J Mol Cell Cardiol 2000;32:2141-2149.
10. Yip HK, Wu CJ, Chang HW, Yang CH, Yeh KH, Chau S, et al: Levels and values of serum high-sensitivity C-reactive protein within 6 hours after the onset of acute myocardial infarction. Chest 2004;126:1417-1422.
11. Mueller C, Buettner HJ, Hodgson JM, Marsch S, Perruchoud AP, Roskamm H, et al: Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1, 042 consecutive patients. Circulation 2002;105:1412-1415.
12. Youssef AA, Change LT, Hang CL, Wu CJ, Cheng CI, Yang CH, et al: Level and value of interleukin-18 in patients with acute myocardial infarction undergoing primary coronary angioplasty. Circ J 2007;71:703-708.
13. Yip HK, Wang PW, Chang LT, Youssef AA, Sheu JJ, Lee FY, et al: Cytotoxic T lymphocyte antigen 4 gene polymorphism associated with ST-segment elevation acute myocardial infarction. Circ J 2007;71:1213-1218.
14. Zeller M, Korandji C, Guilland JC, Sicard P, Vergely C, Lorgis L, et al: Impact of asymmetric dimethylarginine on mortality after acute myocardial infarction. Arterioscler Thromb Vasc Biol 2008;28:954-960.
15. Yip HK, Chang LT, Wu CJ, Sheu JJ, Youssef AA, Pei SN, et al: Autologous bone marrowderived mesenchymal stem cell therapy prevents the damage of viable myocardium and improves rat heart function following acute anterior myocardial infarction. Circ J 2008;72:1336-1346.
16. Velazquez EJ, Pfeffer MA, McMurray JV, Maggioni AP, Rouleau JL, Van de Werf F, et al: VALsartan In Acute myocardial iNfarc-Tion (VALIANT) trial: baseline characteristics in context. Eur J Heart Fail 2003;5:537-544.
17. Garrido AM, Griendling KK: NADPH oxidases and angiotensin II receptor signaling. Mol Cell Endocrinol 2009;302:148-158.
18. Sun CK, Chang LT, Sheu JJ, Chiang CH, Lee FY, Wu CJ, et al: Bone marrow-derived mononuclear cell therapy alleviates left ventricular remodeling and improves heart function in rat-dilated cardiomyopathy. Crit Care Med 2009;37:1197-1205.
19. Thompson PL, Fletcher EE, Katavatis V: Enzymatic indices of myocardial necrosis: influence on short- and long-term prognosis after myocardial infarction. Circulation 1979;59:113-119.
20. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH: Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994;84:1415-1420.
21. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C: A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 1995;184:39-51.
22. Schwartzenberg S, Deutsch V, Maysel-Auslender S, Kissil S, Keren G, George J: Circulating apoptotic progenitor cells: a novel biomarker in patients with acute coronary syndromes. Arterioscler Thromb Vasc Biol 2007;27:27-31.
23. The Thrombolysis in Myocardial Infarction (TIMI) trial: phase 1 findings - TIMI Study Group. N Engl J Med 1985;312:932-936.
24. Halkin A, Singh M, Nikolsky E, Grines CL, Tcheng JE, Garcia E, Cox D, Turco M, Stuckey TD, Na Y, et al: Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J Am Coll Cardiol 2005;45:1397-1405. (Pubitemid 40615609)
25. Geft D, Schwartzenberg S, Rogowsky O, Finkelstein A, Ablin J, Maysel-Auslender S, et al: Circulating apoptotic progenitor cells in patients with congestive heart failure. PLoS One 2008;3:e3238.
26. Shao PL, Chiu CC, Yuen CM, Chua S, Chang LT, Sheu JJ, et al: Shock wave therapy effectively attenuates inflammation in rat carotid artery following endothelial denudation by balloon catheter. Cardiology 2010;115:130-144.
27. Agnoletti L, Curello S, Bachetti T, Malacarne F, Gaia G, Comini L, et al: Serum from patients with severe heart failure downregulates eNOS and is proapoptotic: role of tumor necrosis factor-alpha. Circulation 1999;100:1983-1991.